PROYECTOS
Project 101024387
Development of Mucosal Vaccines Based In Crosslinked-Mucin Glycoproteins And Chitosan-Based Nanodevices
date_range
Duration: from 01 May 2021 to 31 December 2022
(20 months)
Finished
euro
160,932.48 EUR
Of European scope. With a Public character.
Program:
H2020
Subprogram:
EXCELLENT SCIENCE
Researchers
Maria Angeles
Esteban Abad
Leader